目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 24)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 29)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
2.1.2.3 Breakdown of primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
2.7 MARKET LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 41)

4 PREMIUM INSIGHTS (Page No. - 45)
4.1 DIGITAL PATHOLOGY MARKET OVERVIEW
4.2 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER & COUNTRY (2020)
4.3 DIGITAL PATHOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 REGIONAL MIX: DIGITAL PATHOLOGY MARKET (2021-2026)
4.5 DIGITAL PATHOLOGY MARKET: DEVELOPING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW (Page No. - 49)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing adoption of digital pathology to enhance lab efficiency
5.2.1.2 Rising incidence of cancer
5.2.1.3 Growing applications of digital pathology in drug development and companion diagnostics
5.2.2 RESTRAINTS
5.2.2.1 High cost of digital pathology systems
5.2.3 OPPORTUNITIES
5.2.3.1 Introduction of affordable scanners for private pathology practices
5.2.3.2 Growing demand for personalized medicine
5.2.3.3 High growth opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Shortage of trained pathologists
5.3 COVID-19 IMPACT ANALYSIS
5.3.1 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET
5.4 ECOSYSTEM MARKET MAP
5.5 TRENDS IN AVERAGE SELLING PRICE
5.6 IMPACT OF THE NEW IVD REGULATION ON DIFFERENT MARKETS
5.6.1 IMPACT ON CLINICAL LAB SERVICES
5.6.2 IMPACT ON IVD
5.6.3 IMPACT ON DIGITAL PATHOLOGY
5.7 TECHNOLOGY ANALYSIS
5.7.1 ARTIFICIAL INTELLIGENCE (AI) IN DIGITAL PATHOLOGY
5.8 PATENT ANALYSIS
5.8.1 METHODOLOGY
5.8.2 PUBLICATION TRENDS
5.8.3 JURISDICTION ANALYSIS
5.8.4 TOP APPLICANTS

6 DIGITAL PATHOLOGY MARKET, BY PRODUCT (Page No. - 64)
6.1 INTRODUCTION
6.2 SCANNERS
6.2.1 SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PATHOLOGY PRODUCTS MARKET IN 2020
6.2.1.1 Brightfield scanners
6.2.1.2 Other scanners
6.3 SOFTWARE
6.3.1 INTEGRATED SOFTWARE
6.3.1.1 Integrated software segment to dominate the market during the forecast period
6.3.2 STANDALONE SOFTWARE
6.3.2.1 Information management software
6.3.2.1.1 Information management software enables comprehensive integration with any institute’s information systems
6.3.2.2 Image analysis software
6.3.2.2.1 Image analysis software provides easy-to-use solutions for the quantitative evaluation of brightfield slides
6.4 STORAGE SYSTEMS
6.4.1 REQUIREMENT FOR THE SAFE AND RELIABLE STORAGE OF HIGH-QUALITY IMAGES TO ENSURE MARKET GROWTH

7 DIGITAL PATHOLOGY MARKET, BY TYPE (Page No. - 82)
7.1 INTRODUCTION
7.2 HUMAN PATHOLOGY
7.2.1 THE COVID-19 PANDEMIC HAS LED TO AN INCREASING DEMAND FOR DIGITAL PATHOLOGY SOLUTIONS
7.3 VETERINARY PATHOLOGY
7.3.1 VETERINARY DIGITAL PATHOLOGY REDUCES THE TURNAROUND TIME FOR ANIMAL DISEASE DIAGNOSIS─KEY FACTOR DRIVING THE MARKET GROWTH

8 DIGITAL PATHOLOGY MARKET, BY APPLICATION (Page No. - 86)
8.1 INTRODUCTION
8.2 DRUG DISCOVERY
8.2.1 INCREASING R&D SPENDING TO DRIVE THE GROWTH OF THIS SEGMENT
8.3 DISEASE DIAGNOSIS
8.3.1 USE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DIGITAL PATHOLOGY SOLUTIONS FOR DIAGNOSTIC PURPOSES TO DRIVE MARKET GROWTH
8.4 TRAINING & EDUCATION
8.4.1 DIGITAL PATHOLOGY CAN IMPROVE EDUCATION & TRAINING PROVIDED TO PATHOLOGISTS IN ACADEMIC INSTITUTES

9 DIGITAL PATHOLOGY MARKET, BY END USER (Page No. - 95)
9.1 INTRODUCTION
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST & FASTEST-GROWING END USERS OF THE DIGITAL PATHOLOGY MARKET
9.3 HOSPITALS & REFERENCE LABORATORIES
9.3.1 INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS TO DRIVE THE GROWTH OF THIS SEGMENT
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 FUNDING INVESTMENTS AND INITIATIVES TO BOOST THE GROWTH OF THIS END-USER SEGMENT IN THE DIGITAL PATHOLOGY MARKET

10 DIGITAL PATHOLOGY MARKET, BY REGION (Page No. - 106)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Favorable reimbursement scenario for digital pathology in the US to drive the adoption of digital pathology solutions
10.2.2 CANADA
10.2.2.1 Cancer awareness initiatives by the government to drive the market growth in Canada
10.3 EUROPE
10.3.1 UK
10.3.1.1 The UK is the largest market for digital pathology in Europe owing to rising government funding & initiatives
10.3.2 GERMANY
10.3.2.1 High healthcare expenditure and supportive health insurance in Germany to drive the adoption of digital pathology solutions
10.3.3 SWEDEN
10.3.3.1 Increasing government initiatives for the deployment of digital pathology solutions to drive the market growth in Sweden
10.3.4 DENMARK
10.3.4.1 High prevalence of cancer to support the market growth in Denmark
10.3.5 FRANCE
10.3.5.1 Increasing government funding and favorable insurance system are the major factors responsible for the rising adoption of digital pathology solutions in France
10.3.6 REST OF EUROPE (ROE)
10.4 ASIA PACIFIC (APAC)
10.4.1 CHINA
10.4.1.1 Favorable initiatives by the government for the adoption of telepathology in China
10.4.2 JAPAN
10.4.2.1 Universal healthcare reimbursement is driving the adoption of digital pathology solutions in Japan
10.4.3 INDIA
10.4.3.1 Growing number of cancer cases in India to drive market growth
10.4.4 REST OF ASIA PACIFIC (ROAPAC)
10.5 LATIN AMERICA
10.5.1 BRAZIL
10.5.1.1 Growing geriatric population and the subsequent increase in age-related disorders to drive the adoption of digital pathology solutions in Brazil
10.5.2 MEXICO
10.5.2.1 Rising burden of infectious diseases to drive the uptake of digital pathology in Mexico
10.5.3 REST OF LATIN AMERICA (ROLATAM)
10.6 MIDDLE EAST & AFRICA
10.6.1 INFRASTRUCTURAL DEVELOPMENTS IN THE REGION TO BOOST THE ADOPTION OF TECHNOLOGICALLY ADVANCED PATHOLOGY SOLUTIONS

11 COMPETITIVE LANDSCAPE (Page No. - 185)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT-TO-WIN
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
11.4 COMPETITIVE BENCHMARKING
11.5 COMPETITIVE LEADERSHIP MAPPING
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.6 COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES
11.6.1 PROGRESSIVE COMPANIES
11.6.2 DYNAMIC COMPANIES
11.6.3 STARTING BLOCKS
11.6.4 RESPONSIVE COMPANIES
11.7 MARKET SHARE ANALYSIS
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT LAUNCHES AND APPROVALS
11.8.2 DEALS

12 COMPANY PROFILES (Page No. - 200)
12.1 KEY PLAYERS
12.1.1 LEICA BIOSYSTEMS
12.1.1.1 Business overview
12.1.1.2 Products & services offered
12.1.1.3 Recent developments
12.1.1.4 MnM view
12.1.1.4.1 Right-to-win
12.1.1.4.2 Strategic choices made
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 KONINKLIJKE PHILIPS N.V.
12.1.2.1 Business overview
12.1.2.2 products & services Offered
12.1.2.3 Recent developments
12.1.2.4 MnM view
12.1.2.4.1 Right-to-win
12.1.2.4.2 Strategic choices made
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 HAMAMATSU PHOTONICS
12.1.3.1 Business overview
12.1.3.2 Products & Services Offered
12.1.3.3 Recent developments
12.1.3.4 MnM view
12.1.3.4.1 Right-to-win
12.1.3.4.2 Strategic choices made
12.1.4 F. HOFFMANN-LA ROCHE LTD.
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.4 MnM view
12.1.4.4.1 Right-to-win
12.1.4.4.2 Strategic choices made
12.1.5 SECTRA AB
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.4 MnM view
12.1.5.4.1 Right-to-win
12.1.5.4.2 Strategic choices made
12.1.6 AKOYA BIOSCIENCES
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.7 3DHISTECH
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.8 APOLLO ENTERPRISE IMAGING CORP.
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.9 XIFIN, INC.
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.10 HURON DIGITAL PATHOLOGY
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 Recent developments
12.1.11 VISIOPHARM
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.11.3 Recent developments
12.1.12 CORISTA
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.12.3 Recent developments
12.1.13 INDICA LABS
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.13.3 Recent developments
12.1.14 OBJECTIVE PATHOLOGY SERVICES
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.15 OPTRASCAN, INC.
12.1.15.1 Business overview
12.1.15.2 Products offered
12.1.15.3 Recent developments
12.1.16 GLENCOE SOFTWARE, INC.
12.1.16.1 Business overview
12.1.16.2 Products offered
12.1.17 AIFORIA TECHNOLOGIES OY
12.1.17.1 Business overview
12.1.17.2 Products offered
12.1.17.3 Recent developments
12.1.18 PAIGE
12.1.18.1 Business overview
12.1.18.2 Products offered
12.1.18.3 Recent developments
12.1.19 INSPIRATA, INC.
12.1.19.1 Business overview
12.1.19.2 Products offered
12.1.19.3 Recent developments
12.1.20 PROSCIA, INC.
12.1.20.1 Business overview
12.1.20.2 Products offered
12.1.20.3 Recent developments
12.2 OTHER PLAYERS
12.2.1 PATHAI
12.2.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD.
12.2.3 MIKROSCAN TECHNOLOGIES, INC.
12.2.4 MOTIC DIGITAL PATHOLOGY
12.2.5 KANTERON SYSTEMS

13 APPENDIX (Page No. - 250)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

LIST OF TABLES (279 Tables)
TABLE 1 RISK ASSESSMENT: DIGITAL PATHOLOGY MARKET
TABLE 2 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
TABLE 3 US: GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES (2008-2020)
TABLE 4 NUMBER OF INHABITANTS PER PATHOLOGIST, BY COUNTRY, 2020
TABLE 5 DIGITAL PATHOLOGY AI MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 6 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 7 SCANNING MAGNIFICATION AND APPLICATIONS
TABLE 8 DIGITAL PATHOLOGY SCANNERS OFFERED BY KEY MARKET PLAYERS
TABLE 9 DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 10 DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 11 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 12 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2019-2026 (UNITS)
TABLE 13 BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS
TABLE 14 BRIGHTFIELD SCANNERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 15 OTHER SCANNERS OFFERED BY KEY MARKET PLAYERS
TABLE 16 OTHER SCANNERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 17 DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 18 DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 19 DIGITAL PATHOLOGY SOFTWARE MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 20 INTEGRATED SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 21 INTEGRATED SOFTWARE MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 22 STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 23 STANDALONE SOFTWARE MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 24 INFORMATION MANAGEMENT SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 25 INFORMATION MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 26 IMAGE ANALYSIS SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 27 IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 28 STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 29 STORAGE SYSTEMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 30 DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 31 HUMAN DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 32 VETERINARY DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 33 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 34 PRODUCT CROSSED MAPPING FOR DIFFERENT APPLICATIONS
TABLE 35 DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 36 DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION, 2019-2026 (UNITS)
TABLE 37 APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DISCOVERY
TABLE 38 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 39 DIGITAL PATHOLOGY SCANNERS MARKET FOR DRUG DISCOVERY, BY REGION, 2019-2026 (USD MILLION)
TABLE 40 DIGITAL PATHOLOGY SCANNERS MARKET FOR DRUG DISCOVERY, BY REGION, 2019-2026 (UNITS)
TABLE 41 DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 42 DIGITAL PATHOLOGY SCANNERS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2019-2026 (USD MILLION)
TABLE 43 DIGITAL PATHOLOGY SCANNERS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2019-2026 (UNITS)
TABLE 44 DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 45 DIGITAL PATHOLOGY SCANNERS MARKET FOR TRAINING & EDUCATION, BY REGION, 2019-2026 (USD MILLION)
TABLE 46 DIGITAL PATHOLOGY SCANNERS MARKET FOR TRAINING & EDUCATION, BY REGION, 2019-2026 (UNITS)
TABLE 47 DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 48 PRODUCT CROSSED MAPPING FOR DIFFERENT END USERS
TABLE 49 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 50 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (UNITS)
TABLE 51 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 52 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (USD MILLION)
TABLE 53 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (UNITS)
TABLE 54 HOSPITAL DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS
TABLE 55 DIGITAL PATHOLOGY MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 56 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2019-2026 (USD MILLION)
TABLE 57 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2019-2026 (UNITS)
TABLE 58 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 59 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
TABLE 60 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2026 (UNITS)
TABLE 61 DIGITAL PATHOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 62 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 63 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 64 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 65 NORTH AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 66 NORTH AMERICA: STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 67 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 68 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 69 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 70 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION, 2019-2026 (UNITS)
TABLE 71 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 72 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 73 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (UNITS)
TABLE 74 US: CANCER INCIDENCE RATE, 2020
TABLE 75 US: DIGITAL PATHOLOGY CONFERENCES
TABLE 76 US: KEY MACROINDICATORS
TABLE 77 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 78 US: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 79 US: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 80 US: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 81 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 82 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 83 US: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 84 CANADA: CANCER INCIDENCE RATE, 2020
TABLE 85 CANADA: DIGITAL PATHOLOGY INITIATIVES AND FUNDING
TABLE 86 CANADA: KEY MACROINDICATORS
TABLE 87 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 88 CANADA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 89 CANADA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 90 CANADA: DIGITAL PATHOLOGY STANDLONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 91 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 92 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 93 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 94 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 95 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 96 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 97 EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 98 EUROPE: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 99 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 100 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 101 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 102 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION, 2019-2026 (UNITS)
TABLE 103 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 104 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 105 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (UNITS)
TABLE 106 CONFERENCES/COURSES HELD IN THE UK
TABLE 107 UK: KEY MACROINDICATORS
TABLE 108 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 109 UK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 110 UK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 111 UK: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 112 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 113 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 114 UK: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 115 GERMANY: CANCER INCIDENCE RATE, 2020
TABLE 116 GERMANY: KEY MACROINDICATORS
TABLE 117 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 118 GERMANY: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 119 GERMANY: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 120 GERMANY: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 121 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 122 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 123 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 124 SWEDEN: CANCER INCIDENCE RATE, 2020
TABLE 125 SWEDEN: KEY MACROINDICATORS
TABLE 126 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026(USD MILLION)
TABLE 127 SWEDEN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 128 SWEDEN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 129 SWEDEN: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 130 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 131 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 132 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 133 DENMARK: CANCER INCIDENCE RATE, 2020
TABLE 134 DENMARK: KEY MACROINDICATORS
TABLE 135 DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 136 DENMARK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 137 DENMARK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 138 DENMARK: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 139 DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 140 DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 141 DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 142 FRANCE: CANCER INCIDENCE RATE, 2020
TABLE 143 FRANCE: KEY MACROINDICATORS
TABLE 144 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 145 FRANCE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 146 FRANCE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 147 FRANCE: DIGITAL PATHOLOGY STANDLONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 148 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 149 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 150 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 151 ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 152 ROE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 153 ROE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 154 ROE: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 155 ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 156 ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 157 ROE: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 158 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 159 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 160 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 161 ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 162 ASIA PACIFIC: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 163 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 164 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 165 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 166 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION, 2019-2026 (UNITS)
TABLE 167 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 168 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 169 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (UNITS)
TABLE 170 CHINA: CANCER INCIDENCE RATE, 2020
TABLE 171 CHINA: KEY MACROINDICATORS
TABLE 172 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 173 CHINA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 174 CHINA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 175 CHINA: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 176 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 177 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 178 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 179 JAPAN: CANCER INCIDENCE RATE, 2020
TABLE 180 JAPAN: KEY MACROINDICATORS
TABLE 181 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 182 JAPAN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 183 JAPAN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 184 JAPAN: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 185 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 186 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 187 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 188 INDIA: CANCER INCIDENCE RATE, 2020
TABLE 189 INDIA: KEY MACROINDICATORS
TABLE 190 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 191 INDIA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 192 INDIA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 193 INDIA: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 194 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 195 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 196 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 197 ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 198 ROAPAC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 199 ROAPAC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 200 ROAPAC: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 201 ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 202 ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 203 ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 204 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
TABLE 205 LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
TABLE 206 BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
TABLE 207 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 208 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 209 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 210 LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 211 LATIN AMERICA: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 212 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 213 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 214 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION 2019-2026 (USD MILLION)
TABLE 215 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION, 2019-2026 (UNITS)
TABLE 216 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 217 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 218 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (UNITS)
TABLE 219 BRAZIL: CANCER INCIDENCE RATE, 2020
TABLE 220 BRAZIL: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 221 BRAZIL: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 222 BRAZIL: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 223 BRAZIL: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 224 BRAZIL: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 225 BRAZIL: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 226 BRAZIL: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 227 MEXICO: CANCER INCIDENCE RATE, 2020
TABLE 228 MEXICO: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 229 MEXICO: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 230 MEXICO: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 231 MEXICO: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 232 MEXICO: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 233 MEXICO: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 234 MEXICO: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 235 ROLATAM: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 236 ROLATAM: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 237 ROLATAM: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 238 ROLATAM: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 239 ROLATAM: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 240 ROLATAM: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 241 ROLATAM: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 242 AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
TABLE 243 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 244 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 245 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 246 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY STANDALONE SOFTWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 247 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 248 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 249 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 250 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY APPLICATION, 2019-2026 (UNITS)
TABLE 251 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 252 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (USD MILLION)
TABLE 253 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019-2026 (UNITS)
TABLE 254 FOOTPRINT OF COMPANIES IN THE DIGITAL PATHOLOGY MARKET
TABLE 255 PRODUCT: COMPANY FOOTPRINT (25 COMPANIES)
TABLE 256 END USER: COMPANY FOOTPRINT (25 COMPANIES)
TABLE 257 REGION: COMPANY FOOTPRINT (26 COMPANIES)
TABLE 258 KEY PRODUCT LAUNCHES AND APPROVALS
TABLE 259 KEY DEALS
TABLE 260 LEICA BIOSYSTEMS: BUSINESS OVERVIEW
TABLE 261 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
TABLE 262 HAMAMATSU PHOTONICS: BUSINESS OVERVIEW
TABLE 263 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
TABLE 264 SECTRA AB: BUSINESS OVERVIEW
TABLE 265 AKOYA BIOSCIENCES: BUSINESS OVERVIEW
TABLE 266 3DHISTECH: BUSINESS OVERVIEW
TABLE 267 APOLLO ENTERPRISE IMAGING CORP.: BUSINESS OVERVIEW
TABLE 268 XIFIN, INC.: BUSINESS OVERVIEW
TABLE 269 HURON DIGITAL PATHOLOGY: BUSINESS OVERVIEW
TABLE 270 VISIOPHARM: BUSINESS OVERVIEW
TABLE 271 CORISTA: BUSINESS OVERVIEW
TABLE 272 INDICA LABS: BUSINESS OVERVIEW
TABLE 273 OBJECTIVE PATHOLOGY SERVICES: BUSINESS OVERVIEW
TABLE 274 OPTRASCAN, INC.: BUSINESS OVERVIEW
TABLE 275 GLENCOE SOFTWARE, INC.: BUSINESS OVERVIEW
TABLE 276 AIFORIA TECHNOLOGIES OY: BUSINESS OVERVIEW
TABLE 277 PAIGE: BUSINESS OVERVIEW
TABLE 278 INSPIRATA, INC.: BUSINESS OVERVIEW
TABLE 279 PROSCIA, INC.: BUSINESS OVERVIEW

LIST OF FIGURES (43 Figures)
FIGURE 1 DIGITAL PATHOLOGY MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 ILLUSTRATIVE EXAMPLE OF LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION)
FIGURE 8 SUPPLY-SIDE ANALYSIS: DIGITAL PATHOLOGY MARKET (2020)
FIGURE 9 BOTTOM-UP APPROACH
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE DIGITAL PATHOLOGY MARKET (2021-2026)
FIGURE 12 DATA TRIANGULATION METHODOLOGY
FIGURE 13 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 14 DIGITAL PATHOLOGY MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 16 DIGITAL PATHOLOGY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET
FIGURE 18 RISING PREVALENCE OF CANCER IS A KEY FACTOR DRIVING MARKET GROWTH
FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN DIGITAL PATHOLOGY MARKET IN 2020
FIGURE 20 MARKET IN THE UK TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
FIGURE 21 NORTH AMERICA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2021-2026)
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
FIGURE 23 DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 24 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET
FIGURE 25 DIGITAL PATHOLOGY MARKET: ECOSYSTEM MARKET MAP
FIGURE 26 DIGITAL PATHOLOGY MARKET: AVERAGE REGIONAL PRICES OF DIGITAL PATHOLOGY SCANNERS
FIGURE 27 TIMELINE AND TRANSITION TO NEW MDR AND IVDR
FIGURE 28 PUBLICATION TRENDS, 2015-2021
FIGURE 29 JURISDICTION ANALYSIS, 2015-2021
FIGURE 30 TOP APPLICANTS, 2015-2021
FIGURE 31 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
FIGURE 32 DENMARK: CANCER PREVALENCE, 2012-2020
FIGURE 33 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE DIGITAL PATHOLOGY MARKET
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN THE DIGITAL PATHOLOGY MARKET
FIGURE 35 DIGITAL PATHOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
FIGURE 36 DIGITAL PATHOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES (2020)
FIGURE 37 DIGITAL PATHOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
FIGURE 40 HAMAMATSU PHOTONICS: COMPANY SNAPSHOT (2020)
FIGURE 41 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020)
FIGURE 42 SECTRA AB: COMPANY SNAPSHOT (2020)
FIGURE 43 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2020)